MINIMAL DISEASE ACTIVITY

Open Access
Effectiveness of 6-month Use of Secukinumab in Patients With Psoriatic Arthritis in the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
Philip J. Mease, Taylor Blachley, Blessing Dube, Robert R. McLean, Nina Kim, Peter Hur and Alexis Ogdie

The Journal of Rheumatology July 1 2022, 49 (7) 700-706; DOI: https://doi.org/10.3899/jrheum.211033
You have access
Report of the Skin Research Working Groups from the GRAPPA 2017 Annual Meeting
Alice Bendix Gottlieb, Laura C. Coates, Leonieke J.J. van Mens, April W. Armstrong and Joseph F. Merola

The Journal of Rheumatology Supplement June 1 2018, 94 40-43; DOI: https://doi.org/10.3899/jrheum.180137
You have access
Patients with Psoriatic Arthritis Fulfilling the Minimal Disease Activity Criteria Do Not Have Swollen and Tender Joints, but Have Active Skin
Josefina Marin, María Laura Acosta Felquer, Leandro Ferreyra Garrot, Santiago Ruta, Javier Rosa and Enrique R. Soriano

The Journal of Rheumatology May 1 2016, 43 (5) 907-910; DOI: https://doi.org/10.3899/jrheum.151101
You have access
Assessment of Response to Treatment, Remission, and Minimal Disease Activity in Axial Psoriatic Arthritis Treated with Tumor Necrosis Factor Inhibitors
Ennio Lubrano, Wendy J. Parsons and Fabio Massimo Perrotta

The Journal of Rheumatology May 1 2016, 43 (5) 918-923; DOI: https://doi.org/10.3899/jrheum.151404
You have access
Minimal Disease Activity and Remission in Psoriatic Arthritis Patients Treated with Anti-TNF-α Drugs
Fabio Massimo Perrotta, Antonio Marchesoni and Ennio Lubrano

The Journal of Rheumatology February 1 2016, 43 (2) 350-355; DOI: https://doi.org/10.3899/jrheum.150805
You have access
Patient’s Global Assessment as an Outcome Measure for Psoriatic Arthritis in Clinical Practice: A Surrogate for Measuring Low Disease Activity?
Ennio Lubrano, Fabio Massimo Perrotta, Wendy J. Parsons and Antonio Marchesoni

The Journal of Rheumatology December 1 2015, 42 (12) 2332-2338; DOI: https://doi.org/10.3899/jrheum.150595
You have access
Toward Treating to Target in Psoriatic Arthritis
Dafna D. Gladman

The Journal of Rheumatology Supplement November 1 2015, 93 14-16; DOI: https://doi.org/10.3899/jrheum.150626
You have access
Clinical Remission in Patients with Active Psoriatic Arthritis Treated with Adalimumab and Correlations in Joint and Skin Manifestations
Filip Van den Bosch, Arthur Kavanaugh, Martina Kron, Hartmut Kupper and Philip J. Mease

The Journal of Rheumatology June 1 2015, 42 (6) 952-959; DOI: https://doi.org/10.3899/jrheum.140312
You have access
Hemostatic and Fibrinolytic Changes Are Related to Inflammatory Conditions in Patients with Psoriatic Arthritis — Effect of Different Treatments
Matteo Nicola Dario Di Minno, Salvatore Iervolino, Rosario Peluso, Alessandro Di Minno, Pasquale Ambrosino, Raffaele Scarpa and the CaRRDs Study Group

The Journal of Rheumatology April 1 2014, 41 (4) 714-722; DOI: https://doi.org/10.3899/jrheum.130850

Main menu

User menu

Search

MINIMAL DISEASE ACTIVITY

Content

Resources

Subscribers

More